HomeNOX • ASX
add
Noxopharm Ltd
Previous close
$0.086
Day range
$0.081 - $0.082
Year range
$0.058 - $0.15
Market cap
22.49M AUD
Avg Volume
129.56K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.14M | 88.85% |
Operating expense | 1.71M | 69.12% |
Net income | -617.90K | 50.53% |
Net profit margin | -53.99 | 73.81% |
Earnings per share | — | — |
EBITDA | -562.96K | 50.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.18M | -19.01% |
Total assets | 5.47M | -23.62% |
Total liabilities | 1.14M | 96.78% |
Total equity | 4.32M | — |
Shares outstanding | 294.24M | — |
Price to book | 8.60 | — |
Return on assets | -25.77% | — |
Return on capital | -32.58% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -617.90K | 50.53% |
Cash from operations | -630.58K | -158.99% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -639.00K | -159.51% |
Free cash flow | -374.68K | 47.50% |
About
Founded
2015
Headquarters
Website
Employees
1,000
